If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerro-alloy Resources Limited Regulatory News (FAR)

Share Price Information for Ferro-alloy Resources Limited (FAR)

Share Price is delayed by 15 minutes
Get Live Data
4.65    0.00 (0.00%)
Bid:
4.60
Ask:
4.70
Spread: 0.10 (2.174%)
Market Cap: £27.33m
FAR Live PriceLast checked at - London Stock Exchange

Intraday Ferro-alloy Resources Limited Share Chart

Updated Investor Presentation

30 Mar 2021 07:00

RNS Number : 8532T
Ferro-Alloy Resources Limited
30 March 2021
 

 

RNS REACH - NON REGULATORY

29 March 2021

Ferro-Alloy Resources Limited

("Ferro-Alloy" or "the Company")

 

Updated Investor Presentation

 

Ferro-Alloy Resources Limited (LSE: FAR) the vanadium mining and processing company with operations based in Southern Kazakhstan, is pleased to announce publication of its updated investor presentation on the Company's website: http://www.ferro-alloy.com

 

For further information, visit www.ferro-alloy.com or contact:

 

Nick Bridgen, Chief Executive Officer info@ferro-alloy.com

 

Shore Capital (Corporate Broker)

Corporate Advisory: Toby Gibbs / Mark Percy / John More Tel: +44 (0)207 408 4090

Corporate Broking: Jerry Keen

 

VSA Capital Tel: +44 (0)203 005 5000

Andrew Monk / Simon Barton

 

St Brides Partners Limited (Financial PR & IR Adviser)

Catherine Leftley / Megan Dennison Tel: +44 (0)207 236 1177

 

 

 

Further information about Ferro-Alloy Resources Limited

The Company's operations are all located at the Balasausqandiq Deposit in Kyzylordinskaya Oblast in the South of Kazakhstan. Currently the Company has two main business activities:

a) the high grade Balasausqandiq Vanadium Project (the "Project"); and

b) an existing vanadium concentrate processing operation (the "Existing Operation")

 

Balasausqandiq is a very large deposit, situated in Kyzylordinskaya Oblast in Southern Kazakhstan. The ore contains vanadium as the principal product, together with by-products of carbon, molybdenum, uranium, rare earth metals, potassium and aluminium.

The type of ore is very different from the magnetite that comprises the ore of most other producers and the Company's estimated cost of production is less than half that of other primary producers. A reserve on the JORC 2012 basis has been estimated for only the first ore-body which amounts to 23 million tonnes, not including the small amounts of near-surface oxidised material which is in the Inferred resource category. In the system of Reserve estimation used in Kazakhstan the Reserves are estimated to be over 70m tonnes in ore-bodies 1 to 5 but this does not include the full depth of ore-bodies 2-5. Overall, the expectation is that after exploration of the five known ore-bodies the reserves will total over 100m tonnes.

 

The production facilities for the Existing Operation were originally created from a 15,000 tonnes per year pilot plant which was then adapted to treat low-grade concentrates and has been expanded and further adapted to treat a wider variety of raw-materials.

 

The strategy of the Company is to develop both the Existing Operation and the Project in parallel. Although they are located on the same site and use some of the same infrastructure, they are separate operations.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABSGDXIXDDGBC
Date   Source Headline
19th Jul 20237:00 amRNSInvestor Presentation via Investor Meet Company
17th Jul 20237:00 amRNSExisting Operation H1 Production Results
3rd May 20237:00 amRNSInvestor Presentation via Investor Meet Company
2nd May 20232:25 pmRNSDirectors Share Purchase
2nd May 20232:20 pmRNSFull Updated Ore-Body 1 Mineral Resource Estimate
28th Apr 20237:00 amRNS2022 Final Results and Updated Ore-Body 1 MRE
30th Jan 20237:00 amRNSTrading & Operational Update and Grant Funding
20th Dec 20222:05 pmRNSSecond Price Monitoring Extn
20th Dec 20222:00 pmRNSPrice Monitoring Extension
20th Dec 20227:00 amRNSBalasausqandiq Feasibility Study Update
7th Dec 20227:00 amRNSFeasibility Study: Drilling Programme Completes
28th Nov 20224:41 pmRNSSecond Price Monitoring Extn
28th Nov 20224:36 pmRNSPrice Monitoring Extension
28th Nov 20222:05 pmRNSSecond Price Monitoring Extn
28th Nov 20222:00 pmRNSPrice Monitoring Extension
10th Nov 20223:43 pmRNSResult of AGM
13th Oct 20227:00 amRNSNotice of AGM
27th Sep 20226:00 pmRNSHolding(s) in Company
22nd Sep 20227:00 amRNSGrant of Options
15th Sep 20225:15 pmRNSResult of PrimaryBid Offer
15th Sep 202212:20 pmRNSResult of Placing and Subscriptions
15th Sep 20227:02 amRNSPrimaryBid Offer
15th Sep 20227:01 amRNSProposed Placing
15th Sep 20227:00 amRNSInterim Results
1st Jul 20227:38 amRNSBalasausqandiq Feasibility Study Update
1st Jul 20227:00 amRNSBalasausqandiq Feasibility Study Update
29th Jun 20227:00 amRNSGrant of Options
29th Apr 20227:00 amRNSFinal Results
5th Apr 20224:41 pmRNSSecond Price Monitoring Extn
5th Apr 20224:36 pmRNSPrice Monitoring Extension
1st Apr 20227:00 amRNSAppointment of Chief Financial Officer
10th Mar 202211:05 amRNSSecond Price Monitoring Extn
10th Mar 202211:00 amRNSPrice Monitoring Extension
7th Mar 202211:05 amRNSSecond Price Monitoring Extn
7th Mar 202211:01 amRNSPrice Monitoring Extension
2nd Mar 20222:10 pmRNSOperations Update
2nd Mar 20222:06 pmRNSSecond Price Monitoring Extn
2nd Mar 20222:00 pmRNSPrice Monitoring Extension
2nd Mar 202211:05 amRNSSecond Price Monitoring Extn
2nd Mar 202211:00 amRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSAppointment of Joint Broker
13th Jan 20224:40 pmRNSSecond Price Monitoring Extn
13th Jan 20224:35 pmRNSPrice Monitoring Extension
6th Jan 202212:00 pmRNSStatement re: Kazakhstan
3rd Dec 20211:30 pmRNSResult of AGM
1st Dec 20214:41 pmRNSSecond Price Monitoring Extn
1st Dec 20214:35 pmRNSPrice Monitoring Extension
29th Nov 20217:00 amRNSBalasausqandiq Feasibility Study Update
10th Nov 20212:00 pmRNSNotice of AGM
10th Nov 20217:00 amRNSFirst sale of ferro-molybdenum

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.